This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Axolabs

Profile

LGC Axolabs mission: To be the single organization to deliver best solutions for oligonucleotide development, ranging from lead ID, over all clinical stages, up to commercial supply.

LGC Axolabs Nucleic Acid Therapeutics unit offers a unique services portfolio for the development of nucleic acid therapeutics and nucleic acid-based medicines. LGC is dedicated to highest scientific standards fostered by world class expertise and capabilities in oligonucleotide (bio)-analytics, clinical trial support, and cGMP manufacture.